Cargando…
CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371958/ https://www.ncbi.nlm.nih.gov/pubmed/35953728 http://dx.doi.org/10.1007/s00259-022-05932-4 |
_version_ | 1784767275621941248 |
---|---|
author | Lambertini, Alessandro Hartrampf, Philipp E. Higuchi, Takahiro Serfling, Sebastian E. Meybohm, Patrick Schirbel, Andreas Buck, Andreas K. Werner, Rudolf A. |
author_facet | Lambertini, Alessandro Hartrampf, Philipp E. Higuchi, Takahiro Serfling, Sebastian E. Meybohm, Patrick Schirbel, Andreas Buck, Andreas K. Werner, Rudolf A. |
author_sort | Lambertini, Alessandro |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9371958 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-93719582022-08-12 CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection Lambertini, Alessandro Hartrampf, Philipp E. Higuchi, Takahiro Serfling, Sebastian E. Meybohm, Patrick Schirbel, Andreas Buck, Andreas K. Werner, Rudolf A. Eur J Nucl Med Mol Imaging Image of the Month Springer Berlin Heidelberg 2022-08-12 2022 /pmc/articles/PMC9371958/ /pubmed/35953728 http://dx.doi.org/10.1007/s00259-022-05932-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Image of the Month Lambertini, Alessandro Hartrampf, Philipp E. Higuchi, Takahiro Serfling, Sebastian E. Meybohm, Patrick Schirbel, Andreas Buck, Andreas K. Werner, Rudolf A. CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection |
title | CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection |
title_full | CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection |
title_fullStr | CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection |
title_full_unstemmed | CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection |
title_short | CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection |
title_sort | cxcr4-targeted molecular imaging after severe sars-cov-2 infection |
topic | Image of the Month |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371958/ https://www.ncbi.nlm.nih.gov/pubmed/35953728 http://dx.doi.org/10.1007/s00259-022-05932-4 |
work_keys_str_mv | AT lambertinialessandro cxcr4targetedmolecularimagingafterseveresarscov2infection AT hartrampfphilippe cxcr4targetedmolecularimagingafterseveresarscov2infection AT higuchitakahiro cxcr4targetedmolecularimagingafterseveresarscov2infection AT serflingsebastiane cxcr4targetedmolecularimagingafterseveresarscov2infection AT meybohmpatrick cxcr4targetedmolecularimagingafterseveresarscov2infection AT schirbelandreas cxcr4targetedmolecularimagingafterseveresarscov2infection AT buckandreask cxcr4targetedmolecularimagingafterseveresarscov2infection AT wernerrudolfa cxcr4targetedmolecularimagingafterseveresarscov2infection |